• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌预防:我们的篮子里有多少工具?

Prevention of colorectal cancer: How many tools do we have in our basket?

机构信息

Department of Diagnostic and Clinical Medicine and Public Health, University of Modena and Reggio Emilia, Policlinico, Via Del Pozzo 71, Modena 41124, Italy.

Department of Diagnostic and Clinical Medicine and Public Health, University of Modena and Reggio Emilia, Policlinico, Via Del Pozzo 71, Modena 41124, Italy.

出版信息

Eur J Intern Med. 2015 Dec;26(10):752-6. doi: 10.1016/j.ejim.2015.08.019. Epub 2015 Oct 21.

DOI:10.1016/j.ejim.2015.08.019
PMID:26499755
Abstract

Prevention is the main strategy in order to reduce colorectal cancer incidence and mortality. It can be accomplished through primary prevention, using measures affecting factors known to confer higher risk of colorectal cancer, or through secondary prevention, aimed at early diagnosis of cancer or preneoplastic lesions in groups of subjects at increased risk of cancer. Although primary prevention should be the goal for future years, because it acts on the probable causes of colorectal cancer, at present it seems that secondary prevention is more effective on colorectal cancer survival, and the approaches which have yielded the most satisfying results, in terms of reduced mortality for cancer, are those aimed at detecting preneoplastic lesions, or cancer at an early stage in selected groups of subjects at average or increased risk of colorectal cancer. These groups are subjects aged 50years or older, affected individuals (gene carriers) or family members of hereditary colorectal cancer syndromes (i.e., Lynch syndrome and familial adenomatous polyposis), and patients with inflammatory bowel diseases. The most effective procedures used, though with some drawbacks, are fecal occult blood tests and colonoscopy. Future research should be addressed to find new approaches that will render preventive strategies more acceptable for the population, and more cost-effective.

摘要

预防是降低结直肠癌发病率和死亡率的主要策略。它可以通过初级预防来实现,即采取影响已知增加结直肠癌风险因素的措施,也可以通过二级预防来实现,即针对癌症或癌前病变在高危人群中的早期诊断。虽然初级预防应该是未来几年的目标,因为它针对结直肠癌的可能原因,但目前看来,二级预防对结直肠癌的生存更有效,并且在降低癌症死亡率方面取得最令人满意结果的方法是针对特定高危人群中的癌前病变或早期癌症进行检测。这些人群是年龄在 50 岁或以上的人群、遗传性结直肠癌综合征(即林奇综合征和家族性腺瘤性息肉病)的受影响个体(基因携带者)或家庭成员,以及炎症性肠病患者。虽然这些方法存在一些缺点,但粪便潜血试验和结肠镜检查是最有效的方法。未来的研究应该致力于寻找新的方法,使预防策略更能被人群接受,并更具成本效益。

相似文献

1
Prevention of colorectal cancer: How many tools do we have in our basket?结直肠癌预防:我们的篮子里有多少工具?
Eur J Intern Med. 2015 Dec;26(10):752-6. doi: 10.1016/j.ejim.2015.08.019. Epub 2015 Oct 21.
2
Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 2018 Update.临床实践指南。结直肠癌的诊断与预防。2018年更新版。
Gastroenterol Hepatol. 2018 Nov;41(9):585-596. doi: 10.1016/j.gastrohep.2018.07.012. Epub 2018 Sep 20.
3
[Prevention and early detection of colorectal carcinoma by endoscopic examinations].[通过内镜检查预防和早期发现结直肠癌]
Z Gastroenterol. 1998 May;36(5):403-14.
4
[Individual screening for colorectal cancer: which strategy for which patient?].[结直肠癌的个体筛查:针对不同患者采用何种策略?]
Rev Med Brux. 2001 Sep;22(4):A203-9.
5
Screening of colorectal cancer.结直肠癌筛查
Surg Oncol Clin N Am. 2005 Oct;14(4):699-722. doi: 10.1016/j.soc.2005.05.009.
6
Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.美国疾病预防控制中心结直肠癌筛查示范项目的临床结果。
Cancer. 2013 Aug 1;119 Suppl 15:2820-33. doi: 10.1002/cncr.28163.
7
[Colorectal cancer: prevention and early detection].[结直肠癌:预防与早期检测]
Dtsch Med Wochenschr. 2015 Sep;140(19):1425-30. doi: 10.1055/s-0041-102940. Epub 2015 Sep 24.
8
Recommended intervals between screening and surveillance colonoscopies.推荐的筛查和监测结肠镜检查之间的间隔。
Mayo Clin Proc. 2013 Aug;88(8):854-8. doi: 10.1016/j.mayocp.2013.04.023.
9
[Screening for colorectal cancer: what is the most effective strategy?].[结直肠癌筛查:最有效的策略是什么?]
Gesundheitswesen. 2005 Nov;67(11):803-8. doi: 10.1055/s-2005-858793.
10
The impact of colorectal cancer screening in a veteran hospital population.退伍军人医院人群中结直肠癌筛查的影响
Am Surg. 2013 Mar;79(3):296-300.

引用本文的文献

1
The value of the platelet mean volume to platelet count ratio (MPV/PC) in the diagnosis of colorectal cancer: A retrospective clinical study.血小板平均体积与血小板计数比值(MPV/PC)在结直肠癌诊断中的价值:一项回顾性临床研究。
Medicine (Baltimore). 2025 Aug 8;104(32):e43543. doi: 10.1097/MD.0000000000043543.
2
Effects of high-quality nursing on surgical site wound infections after colostomy in patients with colorectal cancer.优质护理对结直肠癌患者结肠造口术后手术部位伤口感染的影响。
World J Gastrointest Surg. 2024 Dec 27;16(12):3835-3842. doi: 10.4240/wjgs.v16.i12.3835.
3
Immunotherapy-induced hepatitis in metastatic colorectal cancer: a systematic review and meta-analysis.
转移性结直肠癌中免疫疗法诱导的肝炎:一项系统评价和荟萃分析。
Proc (Bayl Univ Med Cent). 2024 Jul 8;37(5):841-850. doi: 10.1080/08998280.2024.2374161. eCollection 2024.
4
The Role of Tumor Parenchymal and Stromal Ratios in Colorectal Cancer.肿瘤实质与间质比例在结直肠癌中的作用
J Family Reprod Health. 2024 Mar;18(1):1-8. doi: 10.18502/jfrh.v18i1.15433.
5
Chondroitin polymerizing factor promotes development and progression of colorectal cancer via facilitating transcription of VEGFB.软骨素聚合因子通过促进 VEGFB 的转录促进结直肠癌的发展和进展。
J Cell Mol Med. 2024 May;28(10):e18268. doi: 10.1111/jcmm.18268.
6
The Role of Phytonutrient Kaempferol in the Prevention of Gastrointestinal Cancers: Recent Trends and Future Perspectives.植物营养素山奈酚在预防胃肠道癌症中的作用:最新趋势与未来展望
Cancers (Basel). 2024 Apr 27;16(9):1711. doi: 10.3390/cancers16091711.
7
Risk factors affecting patients survival with colorectal cancer in Morocco: survival analysis using an interpretable machine learning approach.影响摩洛哥结直肠癌患者生存的风险因素:使用可解释机器学习方法的生存分析。
Sci Rep. 2024 Feb 12;14(1):3556. doi: 10.1038/s41598-024-51304-3.
8
Genetic and immunologic characteristics of colorectal cancer patients with KRAS mutations and predictive significance of tumor immune microenvironment in adjuvant chemotherapy.KRAS 基因突变的结直肠癌患者的遗传和免疫特征及肿瘤免疫微环境在辅助化疗中的预测意义
Genes Dis. 2023 Jun 19;11(3):100983. doi: 10.1016/j.gendis.2023.05.002. eCollection 2024 May.
9
Function and mechanism of MCM8 in the development and progression of colorectal cancer.MCM8 在结直肠癌发生发展中的功能和作用机制。
J Transl Med. 2023 Sep 14;21(1):623. doi: 10.1186/s12967-023-04084-9.
10
Titin as a potential novel therapeutic target in colorectal cancer.肌联蛋白作为结直肠癌潜在的新型治疗靶点。
J Cell Mol Med. 2023 Oct;27(19):2937-2944. doi: 10.1111/jcmm.17866. Epub 2023 Jul 27.